1207269-27-9

Basic information

• Product Name: C₄₈H₃₈F₆N₆O₄S₂
• Synonyms: C₄₈H₃₈F₆N₆O₄S₂
• CAS NO: 1207269-27-9
• Molecular Weight: 940.99
• Mol File: 1207269-27-9.mol

Chemical Properties

• CAS DataBase Reference: C₄₈H₃₈F₆N₆O₄S₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₈H₃₈F₆N₆O₄S₂(1207269-27-9)
• EPA Substance Registry System: C₄₈H₃₈F₆N₆O₄S₂(1207269-27-9)

Safety Data

• Hazardous Substances Data: 1207269-27-9(Hazardous Substances Data)

Upstream product

• 32281-01-9 4-mercapto-2-methylphenol 
• 101-41-7 benzeneacetic acid methyl ester 
• 6830-82-6 N-methylphenylacetamide 
• 103-82-2 phenylacetic acid 
• 95-48-7 ortho-cresol 
• 3774-53-6 2-methyl-4-thiocyanato-phenol 
• 33931-27-0 4,4'-dithio-bis-(2-methyl-phenol) 
• 1207269-18-8 3-(1'-bromo-benzyl)-4-methyl-1-(4-trifluoromethyl)phenyl-1H-1,2,4-triazole-5(4H)-one 
• 1207269-16-6 N-methyl-2-phenyl-N-(4-trifluoromethyl) phenylacetamide hydrazone 
• 1207269-17-7 3-benzyl-4-methyl-1-(4-trifluoromethyl)-phenyl-1H-1,2,4-triazole-5(4H)-one 

Downstream Products

• 1207268-92-5 ethyl 2,2-dimethyl-2-(3-methyl-4-(1-(3-(4-methyl-5-oxo-1-(4-trifluoromethyl-phenyl)-4,5-dihydrogen-1H-1,2,4-triazolyl))-benzyloxy)-phenylthio)-acetate 
• 1207269-30-4 C₂₄H₂₀F₃N₃O₂S 

Relevant articles and documents

COMPOUND WITH AGITATION EFFECT ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR , AND PREPARATION METHOD AND USE THEREOF

The present invention provides a novel compound of formula I, which has an agitation effect on the peroxisome proliferator-activated receptor subtype δ (PPARδ), to a pharmaceutical composition comprising the compound, to a process for preparation of the compound and to use of the compound in the manufacture of a medicament for treating or preventing a disease which could be treated or prevented by activating PPARδ thereof, said disease is one or more from the group comprising metabolic syndrome, obesity, dyslipidemia, pathoglycemia, insulin resistance, senile dementia and tumors. The present invention also relates to a new intermediate used in the preparation of the novel compound and a process for preparation of the intermediate.

COMPOUND WITH AGITATION EFFECT ON PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR. PROCESS FOR ITS PREPARATION AND USE THEREOF

The present invention provides a novel compound of formula I, which has an agitation effect on the peroxisome proliferator-activated receptor subtype δ (PPARδ), to a pharmaceutical composition comprising the compound, to a process for preparation of the compound and to use of the compound in the manufacture of a medicament for treating or preventing a disease which could be treated or prevented by activating PPARδ thereof, said disease is one or more from the group comprising metabolic syndrome, obesity, dyslipidemia, pathoglycemia, insulin resistance, senile dementia and tumors. The present invention also relates to a new intermediate used in the preparation of the novel compound and a process for preparation of the intermediate.